Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Stanford Law & Policy Review
|
June 24, 2004
What's the use? Law and authority in patenting human genetic material
Jonathan Kahn
Genewatch : a Bulletin of the Committee for Responsible Genetics
|
February 8, 2006
BiDil: false promises: faulty statistics and reasoning have lead to the first "racial medicine"
Jonathan Kahn
Scientific American
|
September 27, 2007
Race in a bottle. Drugmakers are eager to develop medicines targeted at ethnic groups, but so far they have made poor choices based on unsound science
Jonathan Kahn
Nature Biotechnology
|
November 10, 2006
Patenting race
Jonathan Kahn
Brooklyn Law Review
|
July 14, 2009
Race, Genes, and Justice: A Call to Reform the Presentation of Forensic DNA Evidence in Criminal Trials
Jonathan Kahn
Social Studies of Science
|
February 21, 2009
Exploiting race in drug development: BiDil's interim model of pharmacogenomics
Jonathan Kahn
The American Journal of Bioethics : AJOB
|
August 23, 2017
Science Is Complex-So Is Race
Jonathan Kahn
Georgetown Journal of Law & Modern Critical Race Perspectives
|
June 13, 2023
The Legal Weaponization of Racialized DNA: A New Genetic Politics of Affirmative Action
Jonathan Kahn
American Journal of Public Health
|
October 5, 2006
Genes, race, and population: avoiding a collision of categories
Jonathan Kahn
Nature Biotechnology
|
May 10, 2011
Mandating race: how the USPTO is forcing race into biotech patents
Jonathan Kahn
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Stanford Law & Policy Review
|
June 24, 2004
What's the use? Law and authority in patenting human genetic material
Jonathan Kahn
Genewatch : a Bulletin of the Committee for Responsible Genetics
|
February 8, 2006
BiDil: false promises: faulty statistics and reasoning have lead to the first "racial medicine"
Jonathan Kahn
Scientific American
|
September 27, 2007
Race in a bottle. Drugmakers are eager to develop medicines targeted at ethnic groups, but so far they have made poor choices based on unsound science
Jonathan Kahn
Nature Biotechnology
|
November 10, 2006
Patenting race
Jonathan Kahn
Brooklyn Law Review
|
July 14, 2009
Race, Genes, and Justice: A Call to Reform the Presentation of Forensic DNA Evidence in Criminal Trials
Jonathan Kahn
Social Studies of Science
|
February 21, 2009
Exploiting race in drug development: BiDil's interim model of pharmacogenomics
Jonathan Kahn
The American Journal of Bioethics : AJOB
|
August 23, 2017
Science Is Complex-So Is Race
Jonathan Kahn
Georgetown Journal of Law & Modern Critical Race Perspectives
|
June 13, 2023
The Legal Weaponization of Racialized DNA: A New Genetic Politics of Affirmative Action
Jonathan Kahn
American Journal of Public Health
|
October 5, 2006
Genes, race, and population: avoiding a collision of categories
Jonathan Kahn
Nature Biotechnology
|
May 10, 2011
Mandating race: how the USPTO is forcing race into biotech patents
Jonathan Kahn
Page
of 4